Cargando…
In Vivo Modelling of ATP1A3 G316S-Induced Ataxia in C. elegans Using CRISPR/Cas9-Mediated Homologous Recombination Reveals Dominant Loss of Function Defects
The NIH Undiagnosed Diseases Program admitted a male patient with unclassifiable late-onset ataxia-like symptoms. Exome sequencing revealed a heterozygous de novo mutation converting glycine 316 to serine in ATP1A3, which might cause disease. ATP1A3 encodes the Na(+)/K(+) ATPase pump α3-subunit. Usi...
Autores principales: | Sorkaç, Altar, Alcantara, Ivan C., Hart, Anne C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148073/ https://www.ncbi.nlm.nih.gov/pubmed/27936181 http://dx.doi.org/10.1371/journal.pone.0167963 |
Ejemplares similares
-
LIN-12/Notch Regulates GABA Signaling at the Caenorhabditis elegans Neuromuscular Junction
por: Sorkaç, Altar, et al.
Publicado: (2018) -
Simplified Gene Knockout by CRISPR-Cas9-Induced Homologous
Recombination
por: Dalvie, Neil C., et al.
Publicado: (2021) -
Targeted recombination of homologous chromosomes using CRISPR‐Cas9
por: Son, Wonseok, et al.
Publicado: (2023) -
Efficient genome editing in Caenorhabditis elegans by CRISPR-targeted homologous recombination
por: Chen, Changchun, et al.
Publicado: (2013) -
Engineering the Caenorhabditis elegans Genome Using Cas9-Triggered Homologous Recombination
por: Dickinson, Daniel J., et al.
Publicado: (2013)